Recruiting
Phase 2

Elacestrant & Abemaciclib

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT07209449

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Abemaciclib

Elacestrant

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-31. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2025-10-07.